Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giacomini

Showing results (311-320 of 378) with videos related to

Pageof 38
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additivesLing Zou, Peter Spanogiannopoulos, Lindsey M Pieper, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2006
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variantsIlaria Badagnani, Richard A Castro, Travis R Taylor, et al.
Clinical Pharmacology and Therapeutics|May 16, 2018
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment DecisionMaciej J Zamek-Gliszczynski, Xiaoyan Chu, Jack A Cook, et al.
Clinical Pharmacology and Therapeutics|October 23, 2018
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter ConsortiumXiaoyan Chu, Mingxiang Liao, Hong Shen, et al.
Molecular Pharmacology|August 26, 2006
Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5)Thomas J Urban, Renata C Gallagher, Chaline Brown, et al.
Clinical Pharmacology and Therapeutics|July 15, 2016
A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on MetforminS Goswami, S W Yee, F Xu, et al.
Clinical Pharmacology and Therapeutics|June 20, 2013
International Transporter Consortium commentary on clinically important transporter polymorphismsK M Giacomini, P V Balimane, S K Cho, et al.
Journal of Molecular Biology|December 9, 2008
Selecting optimum eukaryotic integral membrane proteins for structure determination by rapid expression and solubilization screeningMin Li, Franklin A Hays, Zygy Roe-Zurz, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2022
Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter DeficiencyMegan L Koleske, Gregory McInnes, Julia E H Brown, et al.
Clinical Pharmacology and Therapeutics|August 11, 2017
New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision MedicineM V Relling, R M Krauss, D M Roden, et al.
Pageof 38

Showing results (311-320 of 378) with videos related to

Sort By:
Pageof 38
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additivesLing Zou, Peter Spanogiannopoulos, Lindsey M Pieper, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2006
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variantsIlaria Badagnani, Richard A Castro, Travis R Taylor, et al.
Clinical Pharmacology and Therapeutics|May 16, 2018
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment DecisionMaciej J Zamek-Gliszczynski, Xiaoyan Chu, Jack A Cook, et al.
Clinical Pharmacology and Therapeutics|October 23, 2018
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter ConsortiumXiaoyan Chu, Mingxiang Liao, Hong Shen, et al.
Molecular Pharmacology|August 26, 2006
Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5)Thomas J Urban, Renata C Gallagher, Chaline Brown, et al.
Clinical Pharmacology and Therapeutics|July 15, 2016
A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on MetforminS Goswami, S W Yee, F Xu, et al.
Clinical Pharmacology and Therapeutics|June 20, 2013
International Transporter Consortium commentary on clinically important transporter polymorphismsK M Giacomini, P V Balimane, S K Cho, et al.
Journal of Molecular Biology|December 9, 2008
Selecting optimum eukaryotic integral membrane proteins for structure determination by rapid expression and solubilization screeningMin Li, Franklin A Hays, Zygy Roe-Zurz, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2022
Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter DeficiencyMegan L Koleske, Gregory McInnes, Julia E H Brown, et al.
Clinical Pharmacology and Therapeutics|August 11, 2017
New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision MedicineM V Relling, R M Krauss, D M Roden, et al.
Pageof 38